Login / Signup

Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial.

Connie N HessJudith HsiaIan A CarrollMark R NehlerWolfram RufDavid A MorrowJose Carlos NicolauOtavio BerwangerMichael SzarekWarren H CapellShilpa JohriMichael S PursleyRyan GuptaPatrick S MeehanFrancesco FranchiMark B EffronDebra MarshallChristopher A GraybillSophie P GraybillThomas KeuerMichael R BristowMarc P Bonaca
Published in: Arteriosclerosis, thrombosis, and vascular biology (2023)
gov; Unique identifier: NCT04655586.
Keyphrases
  • coronavirus disease
  • sars cov
  • venous thromboembolism
  • clinical trial
  • study protocol
  • respiratory syndrome coronavirus
  • phase ii
  • direct oral anticoagulants
  • placebo controlled